JP2025509446A5 - - Google Patents
Info
- Publication number
- JP2025509446A5 JP2025509446A5 JP2024553877A JP2024553877A JP2025509446A5 JP 2025509446 A5 JP2025509446 A5 JP 2025509446A5 JP 2024553877 A JP2024553877 A JP 2024553877A JP 2024553877 A JP2024553877 A JP 2024553877A JP 2025509446 A5 JP2025509446 A5 JP 2025509446A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- independently
- formula
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263269209P | 2022-03-11 | 2022-03-11 | |
| US63/269,209 | 2022-03-11 | ||
| US202363479938P | 2023-01-13 | 2023-01-13 | |
| US63/479,938 | 2023-01-13 | ||
| PCT/US2023/064202 WO2023173131A2 (en) | 2022-03-11 | 2023-03-11 | Organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509446A JP2025509446A (ja) | 2025-04-11 |
| JP2025509446A5 true JP2025509446A5 (cg-RX-API-DMAC10.html) | 2026-03-19 |
Family
ID=87936112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553877A Pending JP2025509446A (ja) | 2022-03-11 | 2023-03-11 | 有機化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250186446A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4489758A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025509446A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240158980A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023232171A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3243686A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024010993A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023173131A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7493460B2 (ja) | 2018-05-25 | 2024-05-31 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| WO2020146384A1 (en) | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US12599603B2 (en) | 2019-09-03 | 2026-04-14 | Intra-Cellular Therapies, Inc. | Methods of treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2939676A1 (en) * | 2007-12-06 | 2015-11-04 | Intra-Cellular Therapies, Inc. | Organic compounds |
| DK2970279T3 (da) * | 2013-03-15 | 2020-11-30 | Intra Cellular Therapies Inc | Organiske forbindelser |
| CA2991628C (en) * | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| US11291666B2 (en) * | 2016-09-12 | 2022-04-05 | Intra-Cellular Therapies, Inc. | Uses |
| CA3047579A1 (en) * | 2016-12-22 | 2018-06-28 | Abbvie Inc. | Compositions and methods of enhancing or augmenting type i ifn production |
| JP7493460B2 (ja) * | 2018-05-25 | 2024-05-31 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| WO2020146384A1 (en) * | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US12599603B2 (en) * | 2019-09-03 | 2026-04-14 | Intra-Cellular Therapies, Inc. | Methods of treatment |
-
2023
- 2023-03-11 MX MX2024010993A patent/MX2024010993A/es unknown
- 2023-03-11 WO PCT/US2023/064202 patent/WO2023173131A2/en not_active Ceased
- 2023-03-11 KR KR1020247033626A patent/KR20240158980A/ko active Pending
- 2023-03-11 JP JP2024553877A patent/JP2025509446A/ja active Pending
- 2023-03-11 AU AU2023232171A patent/AU2023232171A1/en active Pending
- 2023-03-11 CA CA3243686A patent/CA3243686A1/en active Pending
- 2023-03-11 US US18/846,037 patent/US20250186446A1/en active Pending
- 2023-03-11 EP EP23767772.9A patent/EP4489758A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220339169A1 (en) | Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlrp3 antagonist | |
| US8642602B2 (en) | Method of inhibiting fibrogenesis and treating fibrotic disease | |
| JP2021526133A5 (cg-RX-API-DMAC10.html) | ||
| EP3311841B1 (en) | Anticancer agent | |
| JP2022538228A5 (cg-RX-API-DMAC10.html) | ||
| JP2020505396A5 (cg-RX-API-DMAC10.html) | ||
| JP6063392B2 (ja) | 自己免疫性障害または臓器免疫拒絶による苦痛を治療するための、インドールアミン−２，３−ジオキシゲナーゼ（ｉｄｏ）を誘導する少なくとも２つの化合物を含んでなる組成物 | |
| JP2022097478A (ja) | 眼疾患を治療するための脱メチル化 | |
| JP2022546711A5 (cg-RX-API-DMAC10.html) | ||
| JP2022533981A5 (cg-RX-API-DMAC10.html) | ||
| JP2025509446A (ja) | 有機化合物 | |
| TW202313559A (zh) | 組蛋白去乙醯化酶6和熱休克蛋白90之雙重抑制劑 | |
| KR20230068277A (ko) | 노화세포 제거용 화합물 및 이의 용도 | |
| US20190255153A1 (en) | Interferon Therapy | |
| JP2011515488A (ja) | 線維性障害を処置する方法 | |
| CN116322674B (zh) | 用于根除癌症干细胞并诱导damp介导的抗肿瘤免疫反应的一组新型copi/arf1-脂解途径抑制剂和化合物 | |
| CN107028952A (zh) | 用于调节细胞因子活性的方法 | |
| JPH09510198A (ja) | キノリン−３−カルボキシアミド化合物の新規な使用 | |
| JP2021525705A5 (cg-RX-API-DMAC10.html) | ||
| JP2021024852A (ja) | 機能不全ミトコンドリアを消去するための複合体、および細胞老化を抑制するための複合体 | |
| US7368287B2 (en) | Use of L-α-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro | |
| WO2024059878A2 (en) | Drugs targeting telomerase reverse transcriptase (tert) for treatment of cancers | |
| KR20220011562A (ko) | 급성 골수성 백혈병에서의 재발 위험 감소 및 생존 연장을 위한 방법 및 조성물 | |
| US12251376B2 (en) | Combinations with thiazolidinediones for use in the prevention or treatment of abnormal bone growth | |
| TW202421108A (zh) | 用於預防或治療癌症且含有萘醌系化合物及免疫檢查點抑制劑作為活性成分的藥學組成物 |